NDC 70000-0263-01 - LEADER CHILDRENS IBUPROFEN
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70000-0263
- Requested NDC
- 70000-0263-01
- Package NDCs from labels
- 70000-0263-1, 70000-0263-2, 70000-0263-3, 70000-0263-01
- Manufacturer
- Cardinal Health 110, LLC. dba Leader
- Effective date
- 2025-03-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LEADER CHILDRENS IBUPROFEN - Cardinal Health 110, LLC. dba Leader | Cardinal Health 110, LLC. dba Leader | 2025-03-03 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70000-0263-1 | LEADER CHILDRENS IBUPROFEN | 1 in 1 CARTON | SUSPENSION | 1 | 5 | |
| 70000-0263-1 | LEADER CHILDRENS IBUPROFEN | 120 mL in 1 BOTTLE | SUSPENSION | 120 | 5 | |
| 70000-0263-2 | LEADER CHILDRENS IBUPROFEN | 240 mL in 1 BOTTLE | SUSPENSION | 240 | 5 | |
| 70000-0263-2 | LEADER CHILDRENS IBUPROFEN | 1 in 1 CARTON | SUSPENSION | 1 | 5 | |
| 70000-0263-3 | LEADER CHILDRENS IBUPROFEN | 150 mL in 1 BOTTLE | SUSPENSION | 150 | 5 | |
| 70000-0263-3 | LEADER CHILDRENS IBUPROFEN | 1 in 1 CARTON | SUSPENSION | 1 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70000-0263 | LEADER CHILDRENS IBUPROFEN (IBUPROFEN) SUSPENSION [CARDINAL HEALTH 110, LLC. DBA LEADER] | 5 | Current NDC, Legacy NDC, 6 package rows | 20250305_913a4bd0-0784-45b4-b05e-3e7c016bbb86.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70000-0263-1 | ML - Milliliter | 70000-0263 | fbb179f2-5d83-4b39-a4c8-7f816a8d06e2 | 1 | 2017-11-06 |
| 70000-0263-2 | ML - Milliliter | 70000-0263 | fbe88e6f-ef78-4794-b3b0-585c7211eea8 | 1 | 2017-11-06 |
| 70000-0263-3 | ML - Milliliter | 70000-0263 | 5146b58d-9db9-4309-b673-3ed748b15b86 | 1 | 2018-03-08 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| IBUPROFEN | IBUPROFEN | NuCare Pharmaceuticals,Inc. | 9b02607a-6fab-5205-e053-2a95a90afa26 | 2025-01-02 | WK2XYI10QM | |
| Ibuprofen | IBUPROFEN | NuCare Pharmaceuticals,Inc. | fc871659-ce41-1be6-e053-6294a90aa5e4 | 2025-01-02 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Prevention Oncology Mouth Rinse | GLYCERIN | Prevention Health Sciences, Inc. | 1ec9ed1c-bcb6-3a0a-e054-00144ff8d46c | 2025-01-01 | Warnings | PDC6A3C0OX |
| CLENZIDERM THERAPEUTIC MOISTURIZER | GLYCERIN | Obagi Cosmeceuticals LLC | d60e22e3-831e-4787-a82c-e7763c287553 | 2025-01-01 | Warnings | PDC6A3C0OX |
| Ibuprofen | IBUPROFEN | Padagis Israel Pharmaceuticals Ltd | 998f2fcf-0b40-4304-929f-7f2fa42f66d0 | 2024-12-31 | Boxed warning, Warnings, Adverse reactions | 197803 WK2XYI10QM |
| Ibuprofen, Caseys 4good | IBUPROFEN TABLETS | Lil' Drug Store Products, Inc. | 04b3ad8b-bdf9-47f3-e063-6294a90ac350 | 2024-12-31 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Trifecta Pharmaceuticals USA LLC | 09972806-e064-238d-e063-6394a90a7434 | 2024-12-31 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Advanced Rx of Tennessee, LLC | af9af7f4-6314-6217-e053-2995a90a5a0f | 2024-12-31 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Advanced Rx of Tennessee, LLC | b33caad1-8d40-16f2-e053-2a95a90a1b2d | 2024-12-31 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Advanced Rx Pharmacy of Tennessee, LLC | c859cc7a-e13a-7df4-e053-2a95a90a47d6 | 2024-12-31 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Advanced Rx Pharmacy of Tennessee, LLC | bd1ca7af-d640-23fb-e053-2a95a90a8a98 | 2024-12-31 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Advanced Rx Pharmacy of Tennessee, LLC | f18b6a0a-e42f-083d-e053-2995a90a40e4 | 2024-12-31 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Spirit Pharmaceutical LLC | 59c77fd3-5e67-45ec-82ad-44585390c4f3 | 2024-12-30 | Warnings | WK2XYI10QM |
| IBUPROFEN | IBUPROFEN | SPIRIT PHARMACEUTICALS,LLC | 2810122e-3c89-49a2-8dac-db3714cb7b45 | 2024-12-30 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Spirit Pharmaceutical LLC | a96d012e-b132-4e99-b84b-ccd3a9a05cbb | 2024-12-30 | Warnings | WK2XYI10QM |
| Cabinet Pain Reliever and Fever Reducer | IBUPROFEN | Spirit Pharmaceutical LLC | e172a8d8-779d-4ad9-b6b0-08a198a58034 | 2024-12-30 | Warnings | WK2XYI10QM |
| ADVIL PM- diphenhydramine citrate and ibuprofen tablet, coated | ADVIL PM | Lil Drug Store Products, Inc | d1138e15-8ae4-7b49-e053-2995a90a9607 | 2024-12-30 | Warnings | WK2XYI10QM |
| Advil Liqui-Gels | IBUPROFEN CAPSULE, LIQUID-FILLED | Lil' Drug Store Products, Inc. | c459ea1e-dabf-bba6-e053-2995a90af40f | 2024-12-30 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Aurohealth LLC | 09bd3935-526d-4ad1-898a-4f0d9499ebb9 | 2024-12-26 | Warnings | WK2XYI10QM |
| Aacetaminophen and Ibuprofen | ACETAMINOPHEN AND IBUPROFEN | GRANULES USA, INC. | 1dd90684-6505-8e07-e063-6394a90afdf4 | 2024-12-26 | Warnings | WK2XYI10QM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.